NeuroPace, Inc. announced that the U.S. Food and Drug Administration has granted premarket approval for the NeuroPace RNS System, a treatment for adults with partial onset seizures that have not been controlled with two or more antiepileptic drugs.
http://www.hispanicbusiness.com/2013/11/29/neuropace_gets_fda_premarket_approval_for.htm
http://www.hispanicbusiness.com/2013/11/29/neuropace_gets_fda_premarket_approval_for.htm
No comments:
Post a Comment